Research ExplorerPublicationsLow lysine diet in glutaric aciduria type I--effect on anthr...

Low lysine diet in glutaric aciduria type I--effect on anthropometric and biochemical follow-up parameters.

Standard

Low lysine diet in glutaric aciduria type I--effect on anthropometric and biochemical follow-up parameters. / Boy, Nikolas; Haege, Gisela; Heringer, Jana; Assmann, Birgit; Mühlhausen, Chris; Ensenauer, Regina; Maier, Esther M; Lücke, Thomas; Hoffmann, Georg F; Müller, Edith; Burgard, Peter; Kölker, Stefan.

In: J INHERIT METAB DIS, Vol. 36, No. 3, 3, 2013, p. 525-533.

Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

Harvard

Boy, N, Haege, G, Heringer, J, Assmann, B, Mühlhausen, C, Ensenauer, R, Maier, EM, Lücke, T, Hoffmann, GF, Müller, E, Burgard, P & Kölker, S 2013, 'Low lysine diet in glutaric aciduria type I--effect on anthropometric and biochemical follow-up parameters.', J INHERIT METAB DIS, vol. 36, no. 3, 3, pp. 525-533. <http://www.ncbi.nlm.nih.gov/pubmed/22971958?dopt=Citation>

APA

Boy, N., Haege, G., Heringer, J., Assmann, B., Mühlhausen, C., Ensenauer, R., Maier, E. M., Lücke, T., Hoffmann, G. F., Müller, E., Burgard, P., & Kölker, S. (2013). Low lysine diet in glutaric aciduria type I--effect on anthropometric and biochemical follow-up parameters. J INHERIT METAB DIS, 36(3), 525-533. [3]. http://www.ncbi.nlm.nih.gov/pubmed/22971958?dopt=Citation

Vancouver

Boy N, Haege G, Heringer J, Assmann B, Mühlhausen C, Ensenauer R et al. Low lysine diet in glutaric aciduria type I--effect on anthropometric and biochemical follow-up parameters. J INHERIT METAB DIS. 2013;36(3):525-533. 3.

Bibtex

@article{f43ea0a687074c30a97a7f718a37f82c,
title = "Low lysine diet in glutaric aciduria type I--effect on anthropometric and biochemical follow-up parameters.",
abstract = "Metabolic treatment in glutaric aciduria type I (GA-I) including a low lysine diet with lysine-free, tryptophan-reduced amino acid supplements (AAS), carnitine supplementation and early start of emergency treatment during putatively threatening episodes of intermittent febrile illness dramatically improves the outcome and thus has been recommended by an international guideline group (K{\"o}lker et al, J Inherit Metab Dis 30:5-22, 2007). However, possible affection of linear growth, weight gain and biochemical follow-up monitoring has not been studied systematically.",
author = "Nikolas Boy and Gisela Haege and Jana Heringer and Birgit Assmann and Chris M{\"u}hlhausen and Regina Ensenauer and Maier, {Esther M} and Thomas L{\"u}cke and Hoffmann, {Georg F} and Edith M{\"u}ller and Peter Burgard and Stefan K{\"o}lker",
year = "2013",
language = "English",
volume = "36",
pages = "525--533",
journal = "J INHERIT METAB DIS",
issn = "0141-8955",
publisher = "Springer Netherlands",
number = "3",

}

RIS

TY - JOUR

T1 - Low lysine diet in glutaric aciduria type I--effect on anthropometric and biochemical follow-up parameters.

AU - Boy, Nikolas

AU - Haege, Gisela

AU - Heringer, Jana

AU - Assmann, Birgit

AU - Mühlhausen, Chris

AU - Ensenauer, Regina

AU - Maier, Esther M

AU - Lücke, Thomas

AU - Hoffmann, Georg F

AU - Müller, Edith

AU - Burgard, Peter

AU - Kölker, Stefan

PY - 2013

Y1 - 2013

N2 - Metabolic treatment in glutaric aciduria type I (GA-I) including a low lysine diet with lysine-free, tryptophan-reduced amino acid supplements (AAS), carnitine supplementation and early start of emergency treatment during putatively threatening episodes of intermittent febrile illness dramatically improves the outcome and thus has been recommended by an international guideline group (Kölker et al, J Inherit Metab Dis 30:5-22, 2007). However, possible affection of linear growth, weight gain and biochemical follow-up monitoring has not been studied systematically.

AB - Metabolic treatment in glutaric aciduria type I (GA-I) including a low lysine diet with lysine-free, tryptophan-reduced amino acid supplements (AAS), carnitine supplementation and early start of emergency treatment during putatively threatening episodes of intermittent febrile illness dramatically improves the outcome and thus has been recommended by an international guideline group (Kölker et al, J Inherit Metab Dis 30:5-22, 2007). However, possible affection of linear growth, weight gain and biochemical follow-up monitoring has not been studied systematically.

M3 - SCORING: Journal article

VL - 36

SP - 525

EP - 533

JO - J INHERIT METAB DIS

JF - J INHERIT METAB DIS

SN - 0141-8955

IS - 3

M1 - 3

ER -